Lupin vide its letter dated December 01, 2016 has submitted a copy of Revised Press Release as regards expansion of partnership with Eli Lilly and Company (India) (Lilly), to market and sell Lillys rapid-acting Insulin analog Lispro under the brand name Eglucent.
The above information is a part of company’s filings submitted to BSE.